The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of Quality-of-life (QoL) in patients(pts) with advanced solid tumors as screening tool during phase 1 clinical trial recruitment- risk assessment for adverse events and subject replacement.
 
Sidra Anwar
No Relationships to Disclose
 
Wei Tan
No Relationships to Disclose
 
Chi-Chen Hong
No Relationships to Disclose
 
Sonal Admane
No Relationships to Disclose
 
Askia Dozier
Research Funding - Bayer (Inst); EMD serono (Inst); Merrimack (Inst); OncoMed (Inst); Onconova Therapeutics (Inst); PIQUR (Inst)
 
Francine Siedlecki
Research Funding - Cleveland BioLabs (Inst); Novartis (Inst)
 
Amy Whitworth
Research Funding - MedImmune (Inst); Novartis (Inst); Regeneron (Inst)
 
Ann Marie DiRaddo
Research Funding - Cleveland BioLabs (Inst); Kinex (Inst); Sun Pharma (Inst)
 
Dawn DePaolo
No Relationships to Disclose
 
Sandra M Jacob
No Relationships to Disclose
 
Wen Wee Ma
Research Funding - Bayer (Inst); Celgene (Inst); Cleveland BioLabs (Inst); EMD Serono (Inst); Halozyme (Inst); Kinex (Inst); Merrimack (Inst); Novartis (Inst); Onconova Therapeutics (Inst); Pfizer (Inst); Sun Pharma (Inst)
 
Austin Miller
No Relationships to Disclose
 
Alex A. Adjei
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Cleveland BioLabs (Inst); Clovis Oncology (Inst); Merrimack (Inst); Nektar (Inst); Novartis (Inst); PIQUR (Inst); Regeneron (Inst)
 
Grace K. Dy
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merrimack (Inst); Novartis (Inst); OncoMed (Inst)